REIT - Healthcare Facilities
Compare Stocks
5 / 10Stock Comparison
UHT vs HR vs CHCT vs GMRE vs NTST
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Retail
UHT vs HR vs CHCT vs GMRE vs NTST — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Retail |
| Market Cap | $564M | $6.98B | $505M | $94M | $1.70B |
| Revenue (TTM) | $149M | $1.15B | $122M | $148M | $176M |
| Net Income (TTM) | $18M | $-201M | $6M | $2M | $185K |
| Gross Margin | 94.4% | -9.7% | 62.8% | 68.8% | 92.4% |
| Operating Margin | 36.3% | 19.5% | 31.3% | 24.9% | 27.7% |
| Forward P/E | 23.5x | — | 37.6x | 595.7x | 64.8x |
| Total Debt | $386M | $4.15B | $536M | $654M | $0.00 |
| Cash & Equiv. | $7M | $26M | $3M | $7M | $14M |
UHT vs HR vs CHCT vs GMRE vs NTST — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 20 | May 26 | Return |
|---|---|---|---|
| Universal Health Re… (UHT) | 100 | 60.9 | -39.1% |
| Healthcare Realty T… (HR) | 100 | 69.3 | -30.7% |
| Community Healthcar… (CHCT) | 100 | 37.9 | -62.1% |
| Global Medical REIT… (GMRE) | 100 | 54.2 | -45.8% |
| NETSTREIT Corp. (NTST) | 100 | 111.0 | +11.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UHT vs HR vs CHCT vs GMRE vs NTST
Each card shows where this stock fits in a portfolio — not just who wins on paper.
UHT carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 14 yrs, beta 0.24, yield 7.3%
- Beta 0.24, yield 7.3%, current ratio 15.19x
- Lower P/E (23.5x vs 64.8x)
- 11.8% margin vs HR's -17.5%
HR ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.13, Low D/E 88.7%, current ratio 1.75x
- +38.2% vs GMRE's +0.1%
Among these 5 stocks, CHCT doesn't own a clear edge in any measured category.
GMRE is the clearest fit if your priority is long-term compounding.
- 308.1% 10Y total return vs NTST's 40.7%
- 63.5% yield, 5-year raise streak, vs UHT's 7.3%
NTST is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 30.0%, EPS growth 150.0%, 3Y rev CAGR 28.2%
- 30.0% FFO/revenue growth vs HR's -6.9%
- Beta 0.05 vs CHCT's 0.60
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 30.0% FFO/revenue growth vs HR's -6.9% | |
| Value | Lower P/E (23.5x vs 64.8x) | |
| Quality / Margins | 11.8% margin vs HR's -17.5% | |
| Stability / Safety | Beta 0.05 vs CHCT's 0.60 | |
| Dividends | 63.5% yield, 5-year raise streak, vs UHT's 7.3% | |
| Momentum (1Y) | +38.2% vs GMRE's +0.1% | |
| Efficiency (ROA) | 3.1% ROA vs HR's -2.1%, ROIC 4.8% vs 0.7% |
UHT vs HR vs CHCT vs GMRE vs NTST — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
UHT vs HR vs CHCT vs GMRE vs NTST — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
UHT leads in 2 of 6 categories
GMRE leads 1 • NTST leads 1 • HR leads 0 • CHCT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
UHT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HR is the larger business by revenue, generating $1.1B annually — 9.4x CHCT's $122M. UHT is the more profitable business, keeping 11.8% of every revenue dollar as net income compared to HR's -17.5%. On growth, UHT holds the edge at +2.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $149M | $1.1B | $122M | $148M | $176M |
| EBITDAEarnings before interest/tax | $83M | $767M | $82M | $95M | $133M |
| Net IncomeAfter-tax profit | $18M | -$201M | $6M | $2M | $185,000 |
| Free Cash FlowCash after capex | $50M | $201M | $60M | $19M | $106M |
| Gross MarginGross profit ÷ Revenue | +94.4% | -9.7% | +62.8% | +68.8% | +92.4% |
| Operating MarginEBIT ÷ Revenue | +36.3% | +19.5% | +31.3% | +24.9% | +27.7% |
| Net MarginNet income ÷ Revenue | +11.8% | -17.5% | +5.0% | +1.7% | +0.1% |
| FCF MarginFCF ÷ Revenue | +33.3% | +17.5% | +49.4% | +12.6% | +59.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | -10.5% | +4.8% | +18.7% | +27.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -5.9% | +99.8% | +124.4% | -166.2% | +110.6% |
Valuation Metrics
GMRE leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 32.0x trailing earnings, UHT trades at a 87% valuation discount to NTST's 254.5x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than HR's 16.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $564M | $7.0B | $505M | $94M | $1.7B |
| Enterprise ValueMkt cap + debt − cash | $943M | $11.1B | $1.0B | $741M | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | 31.99x | -28.16x | 228.42x | 115.29x | 254.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.49x | — | 37.62x | 595.67x | 64.78x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 4.35x |
| EV / EBITDAEnterprise value multiple | 14.82x | 16.84x | 16.27x | 8.35x | 12.34x |
| Price / SalesMarket cap ÷ Revenue | 5.68x | 5.91x | 4.17x | 0.68x | 8.72x |
| Price / BookPrice ÷ Book value/share | 3.70x | 1.50x | 1.11x | 0.17x | 1.18x |
| Price / FCFMarket cap ÷ FCF | 11.48x | 54.95x | 8.95x | — | 15.52x |
Profitability & Efficiency
UHT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
UHT delivers a 10.9% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-4 for HR. HR carries lower financial leverage with a 0.89x debt-to-equity ratio, signaling a more conservative balance sheet compared to UHT's 2.53x. On the Piotroski fundamental quality scale (0–9), HR scores 7/9 vs GMRE's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.9% | -4.3% | +1.4% | +0.5% | +0.0% |
| ROA (TTM)Return on assets | +3.1% | -2.1% | +0.6% | +0.2% | +0.0% |
| ROICReturn on invested capital | +4.8% | +0.7% | +1.6% | +2.0% | +2.1% |
| ROCEReturn on capital employed | +8.9% | +1.0% | +2.8% | +5.3% | +2.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 5 | 4 | 6 |
| Debt / EquityFinancial leverage | 2.53x | 0.89x | 1.25x | 1.18x | — |
| Net DebtTotal debt minus cash | $379M | $4.1B | $533M | $647M | -$14M |
| Cash & Equiv.Liquid assets | $7M | $26M | $3M | $7M | $14M |
| Total DebtShort + long-term debt | $386M | $4.1B | $536M | $654M | $0 |
| Interest CoverageEBIT ÷ Interest expense | 1.77x | -0.21x | 1.15x | 1.14x | — |
Total Returns (Dividends Reinvested)
NTST leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NTST five years ago would be worth $11,488 today (with dividends reinvested), compared to $5,441 for CHCT. Over the past 12 months, HR leads with a +38.2% total return vs GMRE's +0.1%. The 3-year compound annual growth rate (CAGR) favors NTST at 8.3% vs CHCT's -13.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +5.4% | +19.4% | +11.2% | +6.9% | +15.8% |
| 1-Year ReturnPast 12 months | +12.5% | +38.2% | +14.5% | +0.1% | +32.6% |
| 3-Year ReturnCumulative with dividends | +10.9% | +17.5% | -36.1% | +5.6% | +27.0% |
| 5-Year ReturnCumulative with dividends | -16.7% | +1.1% | -45.6% | -21.4% | +14.9% |
| 10-Year ReturnCumulative with dividends | +18.5% | +39.6% | +83.9% | +308.1% | +40.7% |
| CAGR (3Y)Annualised 3-year return | +3.5% | +5.5% | -13.9% | +1.8% | +8.3% |
Risk & Volatility
Evenly matched — HR and NTST each lead in 1 of 2 comparable metrics.
Risk & Volatility
NTST is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than CHCT's 0.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HR currently trades 97.7% from its 52-week high vs GMRE's 89.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.24x | 0.13x | 0.60x | 0.48x | 0.05x |
| 52-Week HighHighest price in past year | $44.70 | $20.46 | $18.22 | $39.93 | $21.30 |
| 52-Week LowLowest price in past year | $35.26 | $14.09 | $13.23 | $29.05 | $15.24 |
| % of 52W HighCurrent price vs 52-week peak | +90.9% | +97.7% | +97.0% | +89.5% | +95.6% |
| RSI (14)Momentum oscillator 0–100 | 40.2 | 77.5 | 56.9 | 52.7 | 57.7 |
| Avg Volume (50D)Average daily shares traded | 61K | 3.5M | 228K | 130K | 1.2M |
Analyst Outlook
Evenly matched — UHT and GMRE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: UHT as "Hold", HR as "Hold", CHCT as "Hold", GMRE as "Buy", NTST as "Buy". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs -3.3% for HR (target: $19). For income investors, GMRE offers the higher dividend yield at 63.51% vs NTST's 4.10%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $19.33 | $18.50 | $40.00 | $22.03 |
| # AnalystsCovering analysts | 1 | 29 | 16 | 22 | 18 |
| Dividend YieldAnnual dividend ÷ price | +7.3% | +5.5% | +11.3% | +63.5% | +4.1% |
| Dividend StreakConsecutive years of raises | 14 | 0 | 11 | 5 | 0 |
| Dividend / ShareAnnual DPS | $2.96 | $1.11 | $2.00 | $22.70 | $0.83 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% | +0.4% | 0.0% | +0.0% |
UHT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GMRE leads in 1 (Valuation Metrics). 2 tied.
UHT vs HR vs CHCT vs GMRE vs NTST: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is UHT or HR or CHCT or GMRE or NTST a better buy right now?
For growth investors, NETSTREIT Corp.
(NTST) is the stronger pick with 30. 0% revenue growth year-over-year, versus -6. 9% for Healthcare Realty Trust Incorporated (HR). Universal Health Realty Income Trust (UHT) offers the better valuation at 32. 0x trailing P/E (23. 5x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UHT or HR or CHCT or GMRE or NTST?
On trailing P/E, Universal Health Realty Income Trust (UHT) is the cheapest at 32.
0x versus NETSTREIT Corp. at 254. 5x. On forward P/E, Universal Health Realty Income Trust is actually cheaper at 23. 5x.
03Which is the better long-term investment — UHT or HR or CHCT or GMRE or NTST?
Over the past 5 years, NETSTREIT Corp.
(NTST) delivered a total return of +14. 9%, compared to -45. 6% for Community Healthcare Trust Incorporated (CHCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus UHT's +18. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UHT or HR or CHCT or GMRE or NTST?
By beta (market sensitivity over 5 years), NETSTREIT Corp.
(NTST) is the lower-risk stock at 0. 05β versus Community Healthcare Trust Incorporated's 0. 60β — meaning CHCT is approximately 1110% more volatile than NTST relative to the S&P 500. On balance sheet safety, Healthcare Realty Trust Incorporated (HR) carries a lower debt/equity ratio of 89% versus 3% for Universal Health Realty Income Trust — giving it more financial flexibility in a downturn.
05Which is growing faster — UHT or HR or CHCT or GMRE or NTST?
By revenue growth (latest reported year), NETSTREIT Corp.
(NTST) is pulling ahead at 30. 0% versus -6. 9% for Healthcare Realty Trust Incorporated (HR). On earnings-per-share growth, the picture is similar: NETSTREIT Corp. grew EPS 150. 0% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, NTST leads at 28. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UHT or HR or CHCT or GMRE or NTST?
Universal Health Realty Income Trust (UHT) is the more profitable company, earning 17.
8% net margin versus -20. 8% for Healthcare Realty Trust Incorporated — meaning it keeps 17. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UHT leads at 35. 0% versus 8. 0% for HR. At the gross margin level — before operating expenses — NTST leads at 99. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UHT or HR or CHCT or GMRE or NTST more undervalued right now?
On forward earnings alone, Universal Health Realty Income Trust (UHT) trades at 23.
5x forward P/E versus 595. 7x for Global Medical REIT Inc. — 572. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.
08Which pays a better dividend — UHT or HR or CHCT or GMRE or NTST?
All stocks in this comparison pay dividends.
Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 4. 1% for NETSTREIT Corp. (NTST).
09Is UHT or HR or CHCT or GMRE or NTST better for a retirement portfolio?
For long-horizon retirement investors, NETSTREIT Corp.
(NTST) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 05), 4. 1% yield). Both have compounded well over 10 years (NTST: +40. 7%, CHCT: +83. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UHT and HR and CHCT and GMRE and NTST?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: UHT is a small-cap income-oriented stock; HR is a small-cap income-oriented stock; CHCT is a small-cap income-oriented stock; GMRE is a small-cap income-oriented stock; NTST is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.